CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $342,843 | -19.3% | 7,580 | -27.5% | 0.27% | -24.7% |
| Q4 2022 | $424,996 | -57.0% | 10,455 | -30.9% | 0.36% | -40.0% |
| Q3 2022 | $989,000 | +1.5% | 15,130 | -5.6% | 0.59% | -5.9% |
| Q2 2022 | $974,000 | -7.8% | 16,030 | -4.8% | 0.63% | +19.5% |
| Q1 2022 | $1,056,000 | -51.2% | 16,830 | -41.1% | 0.53% | -50.8% |
| Q4 2021 | $2,165,000 | -32.8% | 28,565 | -0.7% | 1.07% | -33.7% |
| Q3 2021 | $3,221,000 | +106.2% | 28,777 | +198.2% | 1.62% | +80.0% |
| Q2 2021 | $1,562,000 | +17.4% | 9,650 | -11.6% | 0.90% | +57.1% |
| Q1 2021 | $1,331,000 | +125.6% | 10,920 | +270.2% | 0.57% | +73.0% |
| Q4 2020 | $590,000 | +138.9% | 2,950 | 0.0% | 0.33% | +120.0% |
| Q3 2020 | $247,000 | – | 2,950 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |